Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: A4H434
Term | Name | Level | Count |
---|---|---|---|
GO:0001680 | tRNA 3'-terminal CCA addition | 9 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 11 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0031123 | RNA 3'-end processing | 7 | 12 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0042780 | tRNA 3'-end processing | 8 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071076 | RNA 3' uridylation | 8 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0005488 | binding | 1 | 12 |
GO:0016740 | transferase activity | 2 | 13 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 12 |
GO:0070569 | uridylyltransferase activity | 5 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0004652 | obsolete polynucleotide adenylyltransferase activity | 6 | 3 |
GO:0004810 | CCA tRNA nucleotidyltransferase activity | 8 | 3 |
GO:0052929 | ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity | 9 | 3 |
GO:0070566 | adenylyltransferase activity | 5 | 3 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 3 |
GO:1990817 | poly(A) RNA polymerase activity | 7 | 3 |
GO:0052927 | CTP:tRNA cytidylyltransferase activity | 5 | 2 |
GO:0070567 | cytidylyltransferase activity | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.271 |
CLV_NRD_NRD_1 | 369 | 371 | PF00675 | 0.390 |
CLV_NRD_NRD_1 | 398 | 400 | PF00675 | 0.491 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.271 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.543 |
CLV_PCSK_KEX2_1 | 369 | 371 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 296 | 298 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 340 | 344 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 399 | 403 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 419 | 423 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 496 | 500 | PF00082 | 0.483 |
DEG_APCC_DBOX_1 | 38 | 46 | PF00400 | 0.504 |
DEG_MDM2_SWIB_1 | 447 | 455 | PF02201 | 0.522 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.346 |
DOC_CKS1_1 | 502 | 507 | PF01111 | 0.367 |
DOC_MAPK_gen_1 | 296 | 304 | PF00069 | 0.520 |
DOC_MAPK_gen_1 | 492 | 499 | PF00069 | 0.500 |
DOC_MAPK_MEF2A_6 | 105 | 113 | PF00069 | 0.562 |
DOC_MAPK_MEF2A_6 | 13 | 21 | PF00069 | 0.363 |
DOC_MAPK_MEF2A_6 | 326 | 333 | PF00069 | 0.487 |
DOC_MAPK_MEF2A_6 | 492 | 499 | PF00069 | 0.502 |
DOC_MAPK_NFAT4_5 | 492 | 500 | PF00069 | 0.490 |
DOC_PP1_RVXF_1 | 190 | 197 | PF00149 | 0.348 |
DOC_PP2B_LxvP_1 | 334 | 337 | PF13499 | 0.346 |
DOC_PP2B_LxvP_1 | 358 | 361 | PF13499 | 0.404 |
DOC_PP2B_LxvP_1 | 466 | 469 | PF13499 | 0.567 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.397 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.576 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.496 |
DOC_USP7_MATH_1 | 361 | 365 | PF00917 | 0.320 |
DOC_USP7_UBL2_3 | 234 | 238 | PF12436 | 0.516 |
DOC_USP7_UBL2_3 | 492 | 496 | PF12436 | 0.482 |
DOC_WW_Pin1_4 | 436 | 441 | PF00397 | 0.390 |
DOC_WW_Pin1_4 | 5 | 10 | PF00397 | 0.362 |
DOC_WW_Pin1_4 | 501 | 506 | PF00397 | 0.564 |
LIG_14-3-3_CanoR_1 | 180 | 190 | PF00244 | 0.513 |
LIG_14-3-3_CanoR_1 | 303 | 308 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 412 | 421 | PF00244 | 0.382 |
LIG_Actin_WH2_2 | 212 | 228 | PF00022 | 0.360 |
LIG_Actin_WH2_2 | 483 | 498 | PF00022 | 0.542 |
LIG_APCC_ABBA_1 | 288 | 293 | PF00400 | 0.555 |
LIG_APCC_ABBAyCdc20_2 | 117 | 123 | PF00400 | 0.501 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.478 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.470 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.452 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.352 |
LIG_FHA_1 | 341 | 347 | PF00498 | 0.498 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.518 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.490 |
LIG_FHA_2 | 180 | 186 | PF00498 | 0.266 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.310 |
LIG_FHA_2 | 405 | 411 | PF00498 | 0.471 |
LIG_FHA_2 | 502 | 508 | PF00498 | 0.551 |
LIG_LIR_Apic_2 | 477 | 482 | PF02991 | 0.563 |
LIG_LIR_Gen_1 | 112 | 121 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 235 | 243 | PF02991 | 0.520 |
LIG_LIR_Gen_1 | 364 | 372 | PF02991 | 0.373 |
LIG_LIR_Gen_1 | 373 | 383 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 444 | 455 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 73 | 81 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 112 | 116 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 364 | 368 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 373 | 378 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 444 | 450 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 73 | 78 | PF02991 | 0.566 |
LIG_NRBOX | 330 | 336 | PF00104 | 0.345 |
LIG_OCRL_FandH_1 | 149 | 161 | PF00620 | 0.539 |
LIG_Pex14_2 | 447 | 451 | PF04695 | 0.523 |
LIG_REV1ctd_RIR_1 | 336 | 344 | PF16727 | 0.534 |
LIG_SH2_CRK | 365 | 369 | PF00017 | 0.268 |
LIG_SH2_CRK | 375 | 379 | PF00017 | 0.258 |
LIG_SH2_CRK | 479 | 483 | PF00017 | 0.582 |
LIG_SH2_STAP1 | 379 | 383 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.491 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.483 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.513 |
LIG_SH3_3 | 304 | 310 | PF00018 | 0.476 |
LIG_SH3_3 | 452 | 458 | PF00018 | 0.462 |
LIG_SH3_3 | 495 | 501 | PF00018 | 0.497 |
LIG_SUMO_SIM_anti_2 | 216 | 224 | PF11976 | 0.492 |
LIG_TRAF2_1 | 474 | 477 | PF00917 | 0.313 |
LIG_TRFH_1 | 333 | 337 | PF08558 | 0.228 |
LIG_TYR_ITIM | 423 | 428 | PF00017 | 0.473 |
LIG_UBA3_1 | 219 | 226 | PF00899 | 0.413 |
LIG_UBA3_1 | 490 | 496 | PF00899 | 0.503 |
MOD_CK1_1 | 436 | 442 | PF00069 | 0.515 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.492 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.502 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.304 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.460 |
MOD_CK2_1 | 381 | 387 | PF00069 | 0.476 |
MOD_CK2_1 | 471 | 477 | PF00069 | 0.312 |
MOD_Cter_Amidation | 272 | 275 | PF01082 | 0.659 |
MOD_GlcNHglycan | 429 | 433 | PF01048 | 0.555 |
MOD_GlcNHglycan | 435 | 438 | PF01048 | 0.531 |
MOD_GlcNHglycan | 447 | 450 | PF01048 | 0.502 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.502 |
MOD_GSK3_1 | 342 | 349 | PF00069 | 0.523 |
MOD_GSK3_1 | 404 | 411 | PF00069 | 0.489 |
MOD_GSK3_1 | 441 | 448 | PF00069 | 0.528 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.497 |
MOD_N-GLC_1 | 203 | 208 | PF02516 | 0.440 |
MOD_N-GLC_1 | 408 | 413 | PF02516 | 0.304 |
MOD_N-GLC_1 | 445 | 450 | PF02516 | 0.349 |
MOD_N-GLC_2 | 352 | 354 | PF02516 | 0.483 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.417 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.509 |
MOD_NEK2_1 | 302 | 307 | PF00069 | 0.417 |
MOD_NEK2_1 | 408 | 413 | PF00069 | 0.422 |
MOD_NEK2_1 | 464 | 469 | PF00069 | 0.417 |
MOD_NEK2_2 | 389 | 394 | PF00069 | 0.586 |
MOD_PK_1 | 303 | 309 | PF00069 | 0.266 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.440 |
MOD_PKA_2 | 302 | 308 | PF00069 | 0.518 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.558 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.480 |
MOD_Plk_1 | 203 | 209 | PF00069 | 0.438 |
MOD_Plk_1 | 215 | 221 | PF00069 | 0.434 |
MOD_Plk_1 | 27 | 33 | PF00069 | 0.419 |
MOD_Plk_1 | 346 | 352 | PF00069 | 0.540 |
MOD_Plk_1 | 379 | 385 | PF00069 | 0.410 |
MOD_Plk_1 | 408 | 414 | PF00069 | 0.446 |
MOD_Plk_1 | 445 | 451 | PF00069 | 0.305 |
MOD_Plk_2-3 | 119 | 125 | PF00069 | 0.397 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.389 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.461 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.502 |
MOD_Plk_4 | 486 | 492 | PF00069 | 0.525 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.490 |
MOD_ProDKin_1 | 436 | 442 | PF00069 | 0.383 |
MOD_ProDKin_1 | 5 | 11 | PF00069 | 0.351 |
MOD_ProDKin_1 | 501 | 507 | PF00069 | 0.563 |
MOD_SUMO_rev_2 | 20 | 27 | PF00179 | 0.523 |
TRG_DiLeu_BaLyEn_6 | 186 | 191 | PF01217 | 0.394 |
TRG_DiLeu_BaLyEn_6 | 367 | 372 | PF01217 | 0.496 |
TRG_ENDOCYTIC_2 | 365 | 368 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 375 | 378 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 425 | 428 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.397 |
TRG_ER_diArg_1 | 168 | 171 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 368 | 370 | PF00400 | 0.407 |
TRG_NES_CRM1_1 | 217 | 230 | PF08389 | 0.438 |
TRG_Pf-PMV_PEXEL_1 | 369 | 373 | PF00026 | 0.502 |
TRG_Pf-PMV_PEXEL_1 | 473 | 477 | PF00026 | 0.317 |
TRG_PTS1 | 515 | 518 | PF00515 | 0.340 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUG7 | Leptomonas seymouri | 64% | 98% |
A0A0S4JS32 | Bodo saltans | 31% | 100% |
A0A0S4JSB5 | Bodo saltans | 45% | 100% |
A0A1X0NL45 | Trypanosomatidae | 47% | 98% |
A0A3S7WNX9 | Leishmania donovani | 82% | 99% |
A0A422NNU3 | Trypanosoma rangeli | 46% | 99% |
A4HSB8 | Leishmania infantum | 82% | 99% |
C9ZYB2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 98% |
E9AKA0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 99% |
O97001 | Leishmania major | 82% | 100% |
V5BI79 | Trypanosoma cruzi | 46% | 98% |